Our Story

Sylvia Health came out of the Novo Nordisk Foundation BioMedical Design Fellowship Programme, a needs-based innovation programme at the University of Copenhagen in Denmark. During four-months of clinical observations at the obstetrics and gynaecology departments of Slagelse Hospital, we encountered many problems within women's health, and witnessed the profound impact of pelvic organ prolapse on women's lives. 

The scale and impact of prolapse shocked us, sparking a deepening interest that persisted throughout the programme. We met with and interviewed patients and clinicians from six countries, delving into disease fundamentals, prevalence, risk factors, stigma, and treatment options. Our immersion led us to a resolute belief that women deserve superior treatment options and that we could be the catalyst for change. 

After the completion of the programme, we formed a company with a mission to deliver accessible treatment options for pelvic organ prolapse that improve outcomes for women. We secured funding from the Danish Innovation Fund, which enabled the initiation of our product development, which you can read more about here. 

We are named after the patron saint of pregnant women: St Sylvia.